COHANCE LIFESCIENCES
|
The Current P/B Ratio of COHANCE LIFESCIENCES is 4.48.
| Share Price | ₹458.0 | Jun 25,2026 |
| Market Cap | ₹17,521.2 Cr | |
| Book Value | ₹3,911.3 Cr | Mar2026 - Consolidated Results |
| Price/Book | 4.48x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of COHANCE LIFESCIENCES
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹17,521.2 Cr] as on Jun 25,2026
(/) Book Value [ ₹3,911.3 Cr] based on Mar2026 - Consolidated Results
(=) P/B Ratio [ 4.48x ]
Thus, for COHANCE LIFESCIENCES , the investors are currently willing to pay '4.48 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of COHANCE LIFESCIENCES !
The chart below summarizes the trend in P/B Ratio of COHANCE LIFESCIENCES over the last five years.
Historical PB (Price/Book ) ratio chart of COHANCE LIFESCIENCES
PB Ratio Performance Analysis for COHANCE LIFESCIENCES
- COHANCE LIFESCIENCES 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 10.78x.
- COHANCE LIFESCIENCES 's operated at median p/b ratio of 10.3x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, COHANCE LIFESCIENCES 's p/b ratio peaked in Mar2025 at 17.58x.
- COHANCE LIFESCIENCES 's p/b ratio hit its five-year low in Mar2023 of 6.93x.
How does COHANCE LIFESCIENCES 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| COHANCE LIFESCIENCES | 3,911.29 | 4.48 | 17,521.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 83,570.10 | 5.35 | 446,792.0 |
| DIVIS LABORATORIES LTD | 16,761.00 | 10.63 | 178,152.0 |
| TORRENT PHARMACEUTICALS LTD | 8,388.43 | 18.23 | 152,915.0 |
| CIPLA LTD | 34,369.40 | 3.39 | 116,354.0 |
| DR REDDYS LABORATORIES LTD | 37,891.50 | 2.97 | 112,681.0 |
| MANKIND PHARMA LTD | 16,300.30 | 6.23 | 101,632.0 |
| LUPIN LTD | 22,448.30 | 4.77 | 107,091.0 |
| ZYDUS LIFESCIENCES LTD | 27,111.40 | 4.05 | 109,875.0 |
| AUROBINDO PHARMA LTD | 37,891.00 | 2.36 | 89,468.4 |
| LAURUS LABS LTD | 5,275.08 | 14.86 | 78,368.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs COHANCE LIFESCIENCES 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.36x |
| Max industry PB | 18.23x |
| Median industry PB | 4.77x |
| Average industry PB | 7.03x |
You may also like the below Video Courses